These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32592004)

  • 1. Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.
    Lung DK; Reese RM; Alarid ET
    Horm Cancer; 2020 Aug; 11(3-4):129-147. PubMed ID: 32592004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.
    Boldes T; Merenbakh-Lamin K; Journo S; Shachar E; Lipson D; Yeheskel A; Pasmanik-Chor M; Rubinek T; Wolf I
    BMC Cancer; 2020 Jun; 20(1):531. PubMed ID: 32513126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells.
    Li Z; Levine KM; Bahreini A; Wang P; Chu D; Park BH; Oesterreich S; Lee AV
    Endocrinology; 2018 Jan; 159(1):285-296. PubMed ID: 29029116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
    Muthukaruppan A; Lasham A; Woad KJ; Black MA; Blenkiron C; Miller LD; Harris G; McCarthy N; Findlay MP; Shelling AN; Print CG
    Clin Breast Cancer; 2017 Apr; 17(2):139-153. PubMed ID: 27756582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis.
    Porras L; Ismail H; Mader S
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
    Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
    Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.
    Campbell TM; Castro MAA; de Oliveira KG; Ponder BAJ; Meyer KB
    Cancer Res; 2018 Jan; 78(2):410-421. PubMed ID: 29180470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K.
    Lahsaee S; Corkery DP; Anthes LE; Holly A; Dellaire G
    Exp Cell Res; 2016 Jan; 340(1):125-31. PubMed ID: 26712520
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of ZBTB7A inhibits cell proliferation of breast cancer through regulating the ubiquitination of estrogen receptor alpha.
    Xiao X; Shen Y; Yin L; He J; Ni X; Luo G; Chen X; Zhu W; Zhong J; Liu J; Peng X; Zu X
    Life Sci; 2019 Dec; 239():117042. PubMed ID: 31715186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESR1 ChIP-Seq Identifies Distinct Ligand-Free ESR1 Genomic Binding Sites in Human Hepatocytes and Liver Tissue.
    Collins JM; Huo Z; Wang D
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin and epigenetic determinants of estrogen receptor alpha (ESR1) signaling.
    Magnani L; Lupien M
    Mol Cell Endocrinol; 2014 Jan; 382(1):633-641. PubMed ID: 23684889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling.
    Gelsomino L; Gu G; Rechoum Y; Beyer AR; Pejerrey SM; Tsimelzon A; Wang T; Huffman K; Ludlow A; Andò S; Fuqua SAW
    Breast Cancer Res Treat; 2016 Jun; 157(2):253-265. PubMed ID: 27178332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models.
    Bahreini A; Li Z; Wang P; Levine KM; Tasdemir N; Cao L; Weir HM; Puhalla SL; Davidson NE; Stern AM; Chu D; Park BH; Lee AV; Oesterreich S
    Breast Cancer Res; 2017 May; 19(1):60. PubMed ID: 28535794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BARX2 and estrogen receptor-alpha (ESR1) coordinately regulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion.
    Stevens TA; Meech R
    Oncogene; 2006 Aug; 25(39):5426-35. PubMed ID: 16636675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR.
    Maekawa R; Sato S; Okada M; Lee L; Tamura I; Jozaki K; Kajimura T; Asada H; Yamagata Y; Tamura H; Yamamoto S; Sugino N
    Mol Endocrinol; 2016 Mar; 30(3):335-47. PubMed ID: 26683811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and
    Butler EN; Bensen JT; Chen M; Conway K; Richardson DB; Sun X; Geradts J; Olshan AF; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):67-74. PubMed ID: 29133365
    [No Abstract]   [Full Text] [Related]  

  • 19. Trichostatin A enhances estrogen receptor-alpha repression in MCF-7 breast cancer cells under hypoxia.
    Noh H; Park J; Shim M; Lee Y
    Biochem Biophys Res Commun; 2016 Feb; 470(3):748-752. PubMed ID: 26768368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSF Promotes ER-Positive Breast Cancer Progression via Posttranscriptional Regulation of
    Mitobe Y; Iino K; Takayama KI; Ikeda K; Suzuki T; Aogi K; Kawabata H; Suzuki Y; Horie-Inoue K; Inoue S
    Cancer Res; 2020 Jun; 80(11):2230-2242. PubMed ID: 32213542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.